Viewing Study NCT02862860


Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-03-05 @ 11:30 PM
Study NCT ID: NCT02862860
Status: COMPLETED
Last Update Posted: 2024-02-21
First Post: 2016-07-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Search for a Link Between the Different Variables for Glycaemia and Oxidative Stress or Impaired HDL Function
Sponsor: Centre Hospitalier Universitaire Dijon
Organization:

Study Overview

Official Title: Influence of Glycaemic Variability on Oxidative Stress and High-density Lipoprotein (HDL) Function in Type-1 Diabetes
Status: COMPLETED
Status Verified Date: 2024-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Holter Gly
Brief Summary: As glycaemic variability on the one hand and hypoglycaemia on the other are associated with oxidative stress and inflammation, they are likely, in type-1 diabetic patients, to affect the oxidation of lipoproteins and HDL function, by altering their anti-atherogenic properties.

The aim of this study is thus to determine, in patients with Type 1 Diabetic (T1D) who will wear a glycaemic Holter for 1 week, the glycaemia parameters (mean glycaemia, duration of hypoglycaemia, duration of hyperglycaemia, mean amplitude of glycaemic excursions) associated with proatherogenic alterations in lipoproteins, in particular:

* LDL oxidation
* HDL oxidation and alterations of HDL function (anti-inflammatory capacity, antioxidant capacity)
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: